Alternatives to M-M-R II If You Can't Fill Your Prescription

M-M-R II from Merck has been the dominant MMR vaccine in the U.S. for decades, but it is not your only option. If your pharmacy is out of M-M-R II or you simply cannot get an appointment, there are FDA-approved alternatives that can fully protect you or your child against measles, mumps, and rubella.

Here is what patients and parents need to know about each available option in 2026.

Option 1: PRIORIX — The Fully Interchangeable Alternative

PRIORIX, manufactured by GlaxoSmithKline (GSK), is a live-attenuated MMR vaccine approved by the FDA in 2022. The CDC has explicitly stated that M-M-R II and PRIORIX are "fully interchangeable for all indications for which MMR vaccination is recommended." That is as clear an endorsement as you will find.

Like M-M-R II, PRIORIX contains live attenuated strains of measles, mumps, and rubella viruses. However, it uses slightly different virus strains: the Schwarz measles strain, the RIT 4385 mumps strain (derived from the Jeryl Lynn strain), and the Wistar RA 27/3 rubella strain. Both vaccines deliver comparable efficacy and safety profiles.

Who should consider PRIORIX? Anyone for whom M-M-R II is indicated — children 12 months and older, adults lacking immunity, healthcare workers, and travelers. If your pharmacy has PRIORIX and not M-M-R II, take PRIORIX without hesitation.

Option 2: ProQuad (MMRV) — The 4-in-1 Option for Children

ProQuad is a combination vaccine from Merck that covers measles, mumps, rubella, AND varicella (chickenpox) in a single injection. It is approved for children ages 12 months through 12 years. The obvious advantage is fewer shots — children who need both the MMR and varicella vaccines can receive one injection instead of two.

However, there is a well-documented consideration: when ProQuad (MMRV) is used for the first dose in children 12-23 months, there is a slightly elevated risk of febrile seizures compared to giving separate MMR and varicella vaccines. The CDC notes this risk but also states that the combination is an acceptable option — it is your provider's preference and your child's health history that should guide the decision.

Who should consider ProQuad? Children 12 months to 12 years who need both MMR and varicella vaccines and whose families prefer fewer injection visits. Not recommended for adults or children over 12 years.

How Do the Alternatives Compare?

Here is a quick side-by-side comparison:

M-M-R II: Merck; approved for 12 months+; subcutaneous or intramuscular; most widely used in U.S.

PRIORIX: GSK; approved for 12 months+; subcutaneous; fully interchangeable with M-M-R II; uses Schwarz measles strain

ProQuad (MMRV): Merck; approved for 12 months to 12 years; adds varicella protection; slightly higher febrile seizure risk at first dose

Are There Any Situations Where Only M-M-R II Should Be Used?

No. There are no clinical situations in which M-M-R II is specifically required over PRIORIX. The two are considered therapeutically equivalent. If your provider insists on M-M-R II specifically, it is worth asking why — the answer may simply be habit or historical preference, not a medical necessity.

What If You Need the Vaccine for International Travel?

For international travel, all three products — M-M-R II, PRIORIX, and ProQuad (for children) — provide equivalent protection. Many countries outside the U.S. use PRIORIX or similar GSK products routinely. Any of these vaccines will satisfy documentation requirements for travel, work, or school.

How to Find One of These Alternatives in Stock

When calling pharmacies, ask specifically for both M-M-R II and PRIORIX by name. Many pharmacies carry one but not the other. medfinder can search for all MMR vaccine options at pharmacies near you simultaneously, so you don't have to spend time calling around yourself.

For context on why M-M-R II can be difficult to find, see our explainer: Why Is M-M-R II So Hard to Find? [Explained for 2026]